MECHANISM OF INTERACTION BETWEEN CISPLATIN AND HUMAN RECOMBINANT INTERFERON-GAMMA IN HUMAN OVARIAN-CANCER CELL-LINES

被引:13
作者
NEHME, A
ALBIN, N
CALIARO, MJ
GUICHARD, S
JOZAN, S
JULIA, AM
BUGAT, R
CANAL, P
机构
[1] CTR CLAUDIUS REGAUD,PHARMACOL EXPTL MED ANTICANC GRP,F-31052 TOULOUSE,FRANCE
[2] UNIV TOULOUSE 3,F-31062 TOULOUSE,FRANCE
关键词
D O I
10.1002/ijc.2910610510
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human ovarian carcinoma cells (2008 and its cisplatin-resistant sub-line 2008/CI3*) were sensitized to cisplatin by treatment with human recombinant gamma interferon (IFN gamma). IFN?I produced no significant change in the uptake of CDDP. Exposure of 2008 and 2008/CI3* cells to IFN gamma resulted in a time-dependent decrease of cellular glutathione and total glutathione-S-transferase activity, principally the rr isoform. By contrast, the treatment of 2008 and 2008/CI3* cell lines with IFN gamma induced rather than suppressed metallothionein IIA mRNA levels. IFN gamma changed neither the formation of total platinum-DNA adducts, nor DNA repair. A significant decrease in c-erbB-2 expression was observed both in sensitive and in resistant cell lines after treatment with IFN gamma, and this decrease was dose-dependent. Our results indicate that the mechanism of IFN gamma-induced sensitization in human ovarian-cancer cell lines is multifactorial. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:643 / 648
页数:6
相关论文
共 30 条
[1]  
ADAMS DJ, 1987, J BIOL CHEM, V262, P4888
[2]  
Akerboom T P, 1981, Methods Enzymol, V77, P373
[3]   ENHANCED POTENTIATION OF CISPLATIN CYTO-TOXICITY IN HUMAN OVARIAN-CARCINOMA CELLS BY PROLONGED GLUTATHIONE DEPLETION [J].
ANDREWS, PA ;
SCHIEFER, MA ;
MURPHY, MP ;
HOWELL, SB .
CHEMICO-BIOLOGICAL INTERACTIONS, 1988, 65 (01) :51-58
[4]  
ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35
[5]  
ANDREWS PA, 1988, CANCER RES, V48, P68
[6]  
ANDREWS PA, 1987, CANCER CHEMOTH PHARM, V19, P149
[7]   SERIAL DETERMINATIONS OF GLUTATHIONE LEVELS AND GLUTATHIONE-RELATED ENZYME-ACTIVITIES IN HUMAN-TUMOR CELLS-INVITRO [J].
BATIST, G ;
BEHRENS, BC ;
MAKUCH, R ;
HAMILTON, TC ;
KATKI, AG ;
LOUIE, KG ;
MYERS, CE ;
OZOLS, RF .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (13) :2257-2258
[8]   INHIBITION OF DNA-REPAIR AND SENSITIZATION OF CISPLATIN IN HUMAN OVARIAN-CARCINOMA CELLS BY INTERLEUKIN-1-ALPHA [J].
BENCHEKROUN, MN ;
PARKER, R ;
REED, E ;
SINHA, BK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (01) :294-300
[9]   DETERMINATION OF INTRACELLULAR REDUCED GLUTATHIONE AND GLUTATHIONE RELATED ENZYME-ACTIVITIES IN CISPLATIN-SENSITIVE AND RESISTANT EXPERIMENTAL OVARIAN-CARCINOMA CELL-LINES [J].
CHEN, G ;
FREI, E ;
ZELLER, WJ .
CANCER LETTERS, 1989, 46 (03) :207-211
[10]   ENHANCED DNA-REPAIR AS A MECHANISM OF RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM(II) [J].
EASTMAN, A ;
SCHULTE, N .
BIOCHEMISTRY, 1988, 27 (13) :4730-4734